arrow
A

Ahizechukwu C. Eke

Johns Hopkins University School of Medicine
H指数:29
被引数:3,160

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacokinetics of Efavirenz in Pregnancy and Postpartum with and Without First-line Tuberculosis Drugs: Results from IMPAACT P1026s

妊娠及产后期间使用和不使用一线结核病药物时依非韦伦的药代动力学:IMPAACT P1026s研究结果

2026-10-030
OA
Integrated proteomics and metabolomics for predicting cardiometabolic risk in pregnant women living with HIV: current evidence and future directions

整合蛋白质组学和代谢组学预测HIV感染者孕妇的心代谢风险:当前证据和未来方向

2026-09-300
PRE
Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic Exposure

比克替拉韦在妊娠期和产后期的群体药代动力学:依从性在维持治疗暴露中的作用

2025-12-170
PRE
Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s

氯法齐明在利福平耐药结核病孕妇及产后妇女中的药代动力学与安全性:IMPAACT P1026s研究的结果

2025-10-010
PRE
GS-443902 concentrations in peripheral blood mononuclear cells and dried blood spots among pregnant and non-pregnant women receiving remdesivir for COVID-19 treatment

GS-443902在妊娠期及非妊娠期女性接受瑞德西韦治疗COVID-19期间,外周血单核细胞和干血斑中的浓度

2025-09-030
OAAI
Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s

左氧氟沙星治疗利福平耐药结核病在孕期及产褥期的药代动力学与安全性:IMPAACT P1026s研究的结果

2025-03-280
OA
Lipid and Glucose Profiles in Pregnant Women With Human Immunodeficiency Virus (HIV) on Tenofovir-based Antiretroviral Therapy
2024-09-022
PRE
Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032
2024-06-050
OA
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s
2023-11-155
OA